Arjuna Natural expands stronghold in Europe with curcumin patent approval
The patented BCM-95 (Curcugreen) formulation provides biologically active curcumin with essential oil of turmeric - a 100% natural formulation.
Benny Antony, PhD, joint managing director for Arjuna, says this patent helps to address much confusion in the market regarding curcumin absorption and oral bioavailability.
He explains: "The main problem of curcumin is that it is not absorbed nor retained well in the blood streams. The market has subsequently been flooded with curcumin products laden with synthetic additives in attempts to overcome the issue of bioavailability.
“The composition of BCM-95 contains only turmeric based components and no synthetic or non-turmeric ingredients.
“This composition of turmeric delivers free curcumin into blood and is retained in the body for longer duration."
Arjuna also argues that many brands are toll manufactured at production centres do not complying to current GMP standards.
Antony adds: "Arjuna’s BCM-95 (Curcugreen) is wholly manufactured in its own facility under a fully automated cGMP complied continuous extraction plant—using only solar power.
"This has enabled Arjuna to triple its manufacturing capacity in Coimbatore, India, to meet the growing demand for their brand of curcumin in the coming years."
Trusted status
Arjuna is already a leading brand in the United States and protected by 49 patents (14 in the US, 2 in Japan and 33 in European Countries) for composition and manufacturing processes of curcumin extract.
The BCM-95 formulation is backed by more than 55 published studies worldwide and several on-going studies for its therapeutic activity on multiple health indications. It enjoys GRAS status as a pure and trusted brand for use in medical foods.
